These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 36004038)
1. Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl. Bin Rubaian NF; Almuhaidib SR; Aljarri SA; Alamri AS Cureus; 2022 Jul; 14(7):e27108. PubMed ID: 36004038 [TBL] [Abstract][Full Text] [Related]
2. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine. Cohen OG; Clark AK; Milbar H; Tarlow M Hum Vaccin Immunother; 2021 Nov; 17(11):4097-4098. PubMed ID: 34435935 [TBL] [Abstract][Full Text] [Related]
3. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature. Buckley JE; Landis LN; Rapini RP JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062 [TBL] [Abstract][Full Text] [Related]
4. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination. Drago F; Broccolo F; Ciccarese G Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476 [TBL] [Abstract][Full Text] [Related]
5. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review. Wang CS; Chen HH; Liu SH J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825 [TBL] [Abstract][Full Text] [Related]
6. Pityriasis Rosea after COVID-19 Infection. Prtajin M; Ljubojević Hadžavdić S Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396 [TBL] [Abstract][Full Text] [Related]
8. A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination. Wong N; Cascardo CA; Mansour M; Qian V; Potts GA Cureus; 2023 May; 15(5):e38772. PubMed ID: 37303403 [TBL] [Abstract][Full Text] [Related]
9. Pityriasis Rosea Eruption Following the Administration of Oxford-AstraZeneca Vaccine. Marghalani S; Alghamdi Y; Albrakati BA; Huwait HF; Mohanna AT Cureus; 2024 Mar; 16(3):e56310. PubMed ID: 38628985 [TBL] [Abstract][Full Text] [Related]
10. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine. Alamri A; Alghamdi Y; Alamri SJ; Althaqafi MK; AlQurashi W; Bader BA; Mohanna AT; Almahdi B Cureus; 2022 Feb; 14(2):e22414. PubMed ID: 35371700 [TBL] [Abstract][Full Text] [Related]
11. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review. Pedrazini MC; da Silva MH Dermatol Ther; 2021 Nov; 34(6):e15129. PubMed ID: 34533265 [TBL] [Abstract][Full Text] [Related]
12. Pityriasis following COVID-19 vaccinations: a systematic review. Duzett L; Mercado G; Tasouli-Drakou V; Kane A; Tam A Dermatol Reports; 2024 Mar; 16(1):9742. PubMed ID: 38623364 [TBL] [Abstract][Full Text] [Related]
13. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review. Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660 [TBL] [Abstract][Full Text] [Related]
14. Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination. Leerunyakul K; Pakornphadungsit K; Suchonwanit P Front Med (Lausanne); 2021; 8():752443. PubMed ID: 34557507 [TBL] [Abstract][Full Text] [Related]
15. Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature. Veraldi S; Boneschi V; Cusini M; Maronese CA Dermatol Reports; 2023 Mar; 15(1):9503. PubMed ID: 37063394 [TBL] [Abstract][Full Text] [Related]
16. Domperidone-induced pityriasis rosea-like drug eruption. Saad S; Gammoudi R; Abdessayed N; Denguezli M Clin Case Rep; 2022 Apr; 10(4):e05674. PubMed ID: 35414911 [TBL] [Abstract][Full Text] [Related]
17. Pityriasis Rosea Induced by COVID-19 Vaccination. Khattab E; Christaki E; Pitsios C Eur J Case Rep Intern Med; 2022; 9(2):003164. PubMed ID: 35265550 [TBL] [Abstract][Full Text] [Related]
18. L-lysine therapy to control the clinical evolution of pityriasis rosea: Clinical case report and literature review. Pedrazini MC; Groppo FC Dermatol Ther; 2021 Jan; 34(1):e14679. PubMed ID: 33326128 [TBL] [Abstract][Full Text] [Related]